Literature DB >> 8519570

MR imaging of 495 consecutive cases with sensorineural hearing loss.

W Wu1, K A Thuomas.   

Abstract

PURPOSE: To examine patients with sensorineural hearing loss (SNHL) with MR.
MATERIAL AND METHODS: 495 consecutive patients with SNHL and 120 age-matched healthy controls were examined. Spin-echo (SE) and fast spin-echo (FSE) images were used with 1.5 T equipment.
RESULTS: An intracranial abnormality was found in 211 (42.6%) of the patients with 95 (19.2%) along the acoustic pathway. Eleven of the 95 patients had sensory hearing loss while 84 had neural hearing loss with the retrocochlear auditory pathway affected by lesions. In 62 of the 84 patients, the internal acoustic canal and cerebellopontine angle were involved. Twenty-two patients had intra-axial lesions. The controls had no pathologic changes along the auditory pathway.
CONCLUSION: MR imaging in a patient with SNHL must cover the entire acoustic pathway from the cochlea to the superior temporal gyrus, and all the components of the auditory pathway should be scrutinized. The FSE-technique can be used to detect the lesions causing SNHL. FSE-sequences can replace SE-sequences.

Entities:  

Mesh:

Year:  1995        PMID: 8519570

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  3 in total

1.  Diagnostic value and prognostic significance of MRI findings in sudden sensorineural hearing loss.

Authors:  Jelena Todic; Nils Guinand; Vincent Lenoir; Pascal Senn; Minerva Becker
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-09-15

Review 2.  Diagnostics and therapy of sudden hearing loss.

Authors:  Stefan K Plontke
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2018-02-19

3.  Magnetic resonance imaging in sudden deafness.

Authors:  Hugo Valter Lisboa Ramos; Flávia Alencar Barros; Hélio Yamashita; Norma de Oliveira Penido; Ana Cláudia Valério de Souza; Wellington Yugo Yamaoka
Journal:  Braz J Otorhinolaryngol       Date:  2005-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.